Muhammad Kaleem Iqbal’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


Figure 1. Demonstrates that various growth factors and receptors released by platelets induce angiogenesis.
Figure 2. Schematic representation of activated platelets interaction with cancer cells as well as initiate EMT and both of them induce cancer metastasis.
Figure 3. Diagrammatic representation of the interaction between platelets and cancer cells that induce angiogenesis,
Some platelets targeting drugs that can be used along chemotherapeutics in different types of cancers.
Exploring the platelet and cancer cell interaction in metastasis targeting
  • Article
  • Full-text available

July 2024

·

47 Reads

·

3 Citations

·

·

Muhammad Kaleem Iqbal

·

[...]

·

Platelets are small anucleated cell fragments that ensure the stopping of bleeding. In blood metastasis of cancer, Platelets are essential. One of the most important aspects of cancer metastasis is the interaction between platelets and circulating tumor cells. Platelets are involved in cancer spread and constitute a hazardous collation with the cancer cells. There are various factors involved in hemostasis and thrombosis, which can be activated by several cancer-related stimuli, including extracellular matrix (ECM), adenosine diphosphate (ADP), and Toll-like receptors (TLRs). Furthermore, it has been previously published that platelets build up inside the main tumors, producing growth factors that encourage tumor growth and angiogenesis. Additionally, tumor cells can interact with platelets through aggregation, further protecting cancer cells. Platelets interact both functionally and physically with different types of tumor cells via integrin and other surface receptors. Platelet integrin's primary function is to maintain platelet adhesion and aggregation at vascular damage sites. Pharmacological treatments that target integrin have been shown to effectively inhibit experimental metastasis. This review paper summarized the recent advances and progress of mechanisms in platelet activation and its interaction with cancer cells in metastasis.

Download

Citations (1)


... The first action of the antiangiogenesis medication is to inhibit the intermediaries involved in blood vessel formation. The release of the anti-cancer medication subsequently leads to the effective elimination of cancer cells [66] . A nanoscale, an effective vehicle for the anticancer medication to reach the neoplastic location, enables all of that. ...

Reference:

Innovative Nanoparticle Synthesis and Multifaceted Applications in Medicine and Cancer Therapy
Exploring the platelet and cancer cell interaction in metastasis targeting